Article Information
History
- August 29, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yaseen A. M. M. Elshaier1,
- Ahmed Mostafa2,
- Fernando Valerio-Pascua3,
- Mari L. Tesch4,
- Joshua M. Costin5 and
- Franck F. Rahaghi6,*
- 1Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia, Egypt
- 2Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, Egypt
- 3Department of Critical Care, Hospital CEMESA Cortés, San Pedro Sula, Honduras
- 4Research &Development, Dr. Ferrer BioPharma, Hallandale Beach, Florida, USA
- 5Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, NOVA Southeastern University, Davie, FL, USA
- 6Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Weston, FL, USA
- ↵*Correspondence to: Correspondence:
Franck F. Rahaghi, M.D, M.H.S., F.C.C.P, 2950 Cleveland Clinic Blvd., Weston, FL 33331, +1 (954)290-2278, Email: RAHAGHF{at}ccf.org
Posted August 29, 2023.
Chlorpheniramine Maleate Displays Multiple Modes of Antiviral Action Against SARS-CoV-2: A Mechanistic Study
